Chapter 48: Vulvar Biopsy

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Think about the last time you were driving and that little orange check engine light suddenly pops up on your dashboard.

Oh, the worst feeling.

It's just this incredibly generic, incredibly vague warning.

And, I mean, what do most of us do?

Ignore it.

Exactly.

We ignore it.

The car is still running, right?

So we just sort of hope it magically turns itself off.

But underneath the hood, that one little light could mean something as trivial as like a loose gas cap, or it could mean your entire transmission is about to drop out on the highway.

It really is the perfect analogy for how patients, and frankly, sometimes clinicians, treat certain physical symptoms.

When you see a vague common complaint in your clinical practice, it is dangerously easy to just assume it's the loose gas cap of human biology, you know.

Totally.

And so for everyone joining us for this deep dive today, our mission is to take that exact scenario and apply it to one of the most critical yet often overlooked areas of women's health.

We are pulling the core clinical material from Chapter 48, vulvar biopsy of advanced health assessment of women, and we're going to break it down for your clinical practice.

Because in this specific clinical landscape,

that check engine link we're talking about, it's long -standing pruritus.

Chronic itching.

Right.

And while itching is, you know, a symptom of altus benign conditions, it is also the single most common complaint associated with vulvar cancer.

Wow.

The most common.

Specifically, you're looking out for long -standing pruritus located on the labia minora, usually in the middle or anterior portion.

Okay.

And the statistics outlined in this chapter, they really demand your attention.

I mean, vulvar cancer accounts for 6 % of all gynecologic cancers diagnosed in the U .S.

6%.

Yeah.

And it causes 1 ,500 deaths annually.

That's sobering.

And the demographic is shifting too, right?

Because the text notes that women have a 1 in 333 chance of receiving this diagnosis in their lifetime.

But we traditionally associate this with women over 65.

Right.

And that does remain the most frequent age group, but the incidence is actively rising in younger women.

Okay.

So you really have to be paying attention.

You do.

The critical takeaway for your practice is that about 60 % of cases are diagnosed in the localized stage, and surgery is the usual treatment.

Most of these tumors are squamous cell in origin.

So early detection is the absolute key to reducing mortality rates.

You simply cannot ignore the check engine light.

So let's look under the hood.

A patient comes in complaining of this chronic itching.

Our first step, according to the chapter, is evaluating for non -neoplastic epithelial disorders of the vulvar skin and mucosa.

Right.

We are looking for the physical manifestations of that itching, starting with squamous hyperplasia.

Yeah, so hyperplasia is fundamentally a proliferative response.

The skin is reacting to a chronic irritant or allergen by trying to protect itself.

Like it's building up armor.

Exactly.

It rapidly produces new cells, resulting in this localized thickening of the epidermis, which is called lichenification.

Like the body trying to build a thicker bumper to handle repeated impacts.

And visually, you're looking for thick white patches.

The text notes, these are often raised lesions that are bilaterally symmetric.

And the vulva itself might appear like a dusky red color.

And the skin will be so thickened that it has very prominent skin markings.

Right, which is a classic presentation known as Purdue sign.

Purdue sign.

Yeah, when you see Purdue sign, you are looking at the physical evidence of a long -term environmental battle.

The tissue is just exhausted.

Which brings us to the actual triggers.

Because the chapter provides a list in box 48 .1 of substances that cause this irritation.

And I mean, this list is wild.

It really is.

We're talking laundry detergents, chlorine bleach, propylene glycol, and spermacides nylon giving off formaldehyde vapors.

Oh yeah.

Deodorant on sanitary pads, saliva, semen, hot tub chemicals.

It even lists fiberglass particles left in a washing machine after washing curtains.

I know, it's crazy.

I mean, with so many potential triggers in the modern world, how are you actually supposed to narrow it down during the physical exam?

Well, the clinical clue isn't always what the lesion looks like, but where it is located.

Oh, interesting.

Yeah.

The distribution of the lesions provides your roadmap.

The pattern of erythema and edema will directly mirror the areas of contact with the offending agent.

Okay.

So if the irritation matches the exact cut of a specific type of synthetic underwear, that points you toward the fabric dye or the synthetic fiber itself.

Exactly.

Rather than a reaction to like a vaginal medication, which would pool and localize completely differently.

Precisely.

Distribution is your diagnostic compass, but you must contrast that environmental contact driven hyperplasia with the next major disorder in the text, which is lichensclerosis or LSA.

Right, LSA.

This is not an allergic reaction to fabric softener.

LSA is driven by a complex interaction of hormonal, genetic, and immunologic factors.

And patients usually come to you after a long, super frustrating period of trying to self -diagnose and treat it at home, right?

With like over -the -counter creams that do absolutely nothing.

Oh, constantly.

The primary symptom is intractable itching, sometimes accompanied by vulvodynia, which is chronic vulvar pain.

Ouch.

Yeah.

And visually, the assessment is drastically different from hyperplasia.

You aren't looking for dusky, red, thickened skin.

So what are we looking for?

With LSA, you're looking for bluish -white papules that eventually progress and merge to form thin, white patches.

Oh, the text uses a really vivid descriptor here.

It says, the skin becomes so thin it wrinkles like parchment paper.

Yeah, parchment paper.

Because the underlying pathophysiology involves the dermis actually thinning out and losing its collagen architecture.

The tissue loses its structural integrity.

That makes sense.

So it becomes friable, meaning it tears with the slightest friction, and you'll often see petechiae.

Those are the tiny red or purple spots caused by capillary bleeding under the skin, right?

And this matters immensely because of the risk factor involved.

Four percent of women who have LSA will later develop vulvar cancer.

It's a huge shift.

That transforms this from a standard dermatology complaint into a condition requiring vigilant long -term oncology monitoring.

Wow.

And you have to keep the entire patient in mind here.

Sometimes what's happening on the vulva is just the local broadcast of a systemic disease happening everywhere else in the body.

Back to the car analogy, it's like an electrical fault deep in the car's main computer causing a warning light to flash on the dash.

You can't just fix the bulb, you have to address the main computer.

Perfect way to put it.

Take Bichette's disease, for example.

On the vulva, it presents as small vesicles that ulcerate.

But if you suspect Bichette's, your next step is to ask the patient about their eyes and their mouth.

You are looking for systemic oral ulcerations and uveitis as well as arthritis.

Or pellagra.

The text mentions that one.

The patient might present with hyperpigmentation and peeling of the vulva skin, but you have to pull back and ask about their dietary intake or a history of anorexia.

You'd check their body for dry, scaly skin and look for erythema on other mucous membranes.

Because pellagra is a severe niacin deficiency, causing epithelial breakdown system -wide.

Right.

And diabetes is another major one to catch.

Oh, absolutely.

Chronic pruritus of the vulva and erythema with a gray sheen.

A gray sheen.

Yeah.

The glucose -rich environment alters the local skin flora, making it highly susceptible to fungal infections.

But again, you connect that local gray sheen to systemic dry body skin and changes related to the kidney, retina, and heart.

And then there is Crohn's disease, which has a very specific and honestly quite alarming visual presentation on the vulvar folds.

The text describes them as knife -like slits.

Yeah, it's intense.

Those knife -like slits occur because the granulomatous inflammation characteristic of Crohn's disease can actually track down through the tissue planes from the gastrointestinal tract straight to the vulva.

That is wild.

It is.

And here is the vital clinical pearl from the text regarding these systemic manifestations.

If the systemic condition is well documented, excision of the vulvar lesion may not be necessary.

OK, so if you know the knife -like slits are from an established case of Crohn's, you just manage the Crohn's disease itself.

Right.

But what if it isn't a known systemic issue and it doesn't fit the profile for contact dermatitis?

What's the next step?

The text provides Table 48 .1 to help us navigate other vulvar dermatosis.

Yes, and navigating this table requires a structured approach.

We categorize these dermatosis by their visual type, starting with papulae squamous lesions.

I like to think of this differential process like playing a clinical game of guess who.

Guess who.

Yeah, you're looking at the vulva, but identifying matching lesions on other parts of the body flips down the wrong diagnostic cards to reveal the true culprit.

I like that.

Let's look at psoriasis.

I remember psoriasis presents with mild pruritus on the vulva, showing up as red plaques or silvery scales, and if you scratch those scales, you get these tiny bleeding points beneath them.

Right.

That bleeding is known as the ospit sign.

It happens because the capillaries right under those thinned epidermal plaques are dilated and super fragile.

So where are our guess who check locations for psoriasis?

You check the scalp, knees, elbows, and sacrum for those classic silvery plaques.

Got it.

What about lichen planus?

On the vulva, you see purplish plaques defined by cross -hatched skin lines.

To confirm lichen planus, you look elsewhere.

You check the wrists, lumbar back, and thighs for flat -topped papules.

Okay.

Critically, you check the buccal mucosa inside the mouth for a lacy pattern.

Inside the cheek.

Exactly.

That lacy network of white lines is pathognomonic.

If you see it, you flip down the other cards.

Boom.

Diagnosis.

And seborrheic dermatitis.

On the vulva, we'd see yellow or red lesions covered by greasy scales.

The matching locations to check there are areas rich in sebaceous glands.

You want to examine the face, the scalp, and particularly the eyebrows and hairline.

Okay.

So that covers the papulesquamous lesions.

Moving to vesiculobulous lesions, the ones that form blisters.

The standout here is erythema multiform.

Yeah.

This often follows a history of recent genital herpes or a drug allergy.

It is a systemic immune response, and you are looking for iris -shaped or target lesions.

Target lesions.

And where are the giveaway matching locations to examine?

The palms of the hands and the soles of the feet.

Easy enough.

Lastly, infections.

Folliculitis versus impetigo.

So folliculitis presents as tiny red papules with a white pustular center that is explicitly punctured by a hair shaft.

Okay.

So it's a hair thing.

Right.

Impetigo is a mechanical infection of the follicle itself, so you can check any of the hairy areas on the body.

And impetigo.

Impetigo, conversely, is a superficial ulcer with a classic honey -yellow crust, usually spread from a bacterial infection on another body part.

Okay.

So if our Guess Who game fails and we still can't identify the culprit clinically, how do we safely force an answer?

When do we pull the trigger on a biopsy?

The text provides very clear triggers for biopsy.

First, any white lesion of the vulva must undergo biopsy if short -term medical treatment is unsuccessful.

Any white lesion?

A key mechanism here is that two -thirds of these abnormal lesions appear aceto -white, meaning they turn white when 5 % acetic acid or vinegar is applied.

Wait, hold on.

Before we talk about acetic acid, I remember being taught to use toluidine blue dye to map out these lesions.

Are we skipping that step entirely now?

We are.

The clinical standard has definitively shifted.

Really?

Yeah.

The text explicitly states that toluidine blue dye is no longer used because it has an unacceptably high rate of both false positive and false negative results.

Wow, okay.

Good to know.

You want to stick to 5 % acetic acid.

It works because the acid dehydrates the cells and coagulates nuclear proteins.

And that makes them turn white.

Right.

Abnormal or precancerous cells have much denser nuclei, so they reflect light and turn distinctly white.

Got it.

Toss the blue dye, stick to the vinegar.

What are the other biopsy triggers?

Well, any suspicious lesions of any color and any persistent ulcerations, they must be excised.

Furthermore, any visible lesion for which a definitive diagnosis simply cannot be made clinically,

any suspicion of possible malignancy, and any visible lesion with a presumed diagnosis that is just not responding to topical therapy.

Makes sense.

And when you are weighing those triggers, you really have to factor in the risk multipliers from the patient's history.

Oh, absolutely.

Because the text mentions two specific factors that cause the risk of cancer to absolutely spike.

Smoking and HPV -16 infection.

Right.

If a patient is seropositive for HPV, she is three and a half times more likely to develop in situ disease and more than two and a half times more likely to develop invasive disease.

And the smoking multiplier is staggering.

It really is.

The more a woman smokes and the longer she smokes, the greater the risk.

Current smokers are at a six and a half times higher risk for in -situ disease.

Six and a half.

Yeah, and three times the risk for invasive disease.

Smoking acts as a massive multiplier because the carcinogens actually concentrate in cervical and vulvar mucus.

Oh, wow.

I didn't know they concentrated there.

They do.

And simultaneously, smoking suppresses the local immune system's ability to fight off the HPV infection.

It is a perfect storm for dysplasia.

Which brings us to the biopsy procedure itself.

So this is a 15 -minute simple office procedure with minimal discomfort appropriate for lesions smaller than 0 .5 centimeters.

If the lesion is larger than 0 .5 centimeters, your protocol is to refer the patient to a gynecologist.

However, the text emphasizes that excising all applicable lesions, particularly fissures, ulcerations, or thick plaques, is mandatory.

Even if they are tiny, the risk of cancer, though only one to two percent, is present.

And a histologic finding is the only way to get a definitive diagnosis.

It must be a full thickness sample.

Okay, let's walk through the setup.

Good lighting is obvious.

Magnification is essential using either a colposcope or a large hand lens.

You've applied your 5 % acetic acid and you've identified the acetyl -white area.

Now for anesthesia, the text calls this the art of the wheel.

The art of the wheel, yes.

We're using 1 % xylocaine without epinephrine injected subdermally with a fine 25 gauge needle, about 0 .5 to 1 ml per site.

But why are we trying to create this 4 to 5 millimeter wheel under the skin?

It is about fluid mechanics.

By injecting the anesthetic to create a raised fluid pocket, or wheel, you are physically lifting the lesion up and away from the deeper dermal structures.

Oh, so it just isolates it?

Exactly.

This makes it much easier to isolate and cut safely.

Additionally, that localized fluid pressure acts as a mechanical tourniquet, promoting local vasoconstriction to significantly minimize blood loss during the punch.

Clever.

So now for the physical skill itself, the punch.

We're using a Keyes Punch biopsy, usually a 2, 3, or 4 millimeter size.

It looks and functions a bit like taking a core sample of an engine block.

Pretty much.

First, you must hold the surrounding skin taut with your opposite hand or recruit an assistant to do so.

This mechanical tension prevents the tissue from bunching up and guarantees a clean cut.

You place the circular punch over the site, press down, and rotate it back and forth three or four times, boring out the tissue in a circular manner.

Then you pull the punch away, you grasp that little plug of tissue sample gently with your fine iris forceps, and to free it, you snip the dermal base transversely with either fine sterile scissors or a number 11 scalpel blade.

Right, and if that tissue plug accidentally gets stuck inside the punch instrument itself, the text notes a very practical tip.

Oh, what is it?

Just use a sterile toothpick to gently dislodge it.

Oh, simple and effective, I love that.

After the sample is out, we need to handle hemostasis, or bleeding control.

Right, and because the dermis contains relatively few large blood vessels, bleeding is usually minimal.

Often, just applying pressure with a sterile gauze sponge or even a sanitary pad is enough.

If needed, you can apply a small amount of Monsil's solution over the site to chemically cauterize it.

If the bleeding is unusually persistent, you would add a single suture using 4 -0 Vikral or Chromic.

And finally, laboratory preparation and documentation.

You place the full thickness sample in formalin, but there is a critical rule from the text here.

Very critical.

If you are taking biopsy samples from different sites on the vulva, they must be placed in entirely separate formalin containers, and each must be clearly labeled by its specific anatomical site.

You absolutely cannot mix them in one jar.

Why not?

The pathologist needs those separate containers to map out exactly where the pathology is located.

If the results come back positive from malignancy, the surgeon needs to know the precise margins for a wide excision.

Makes total sense.

Okay, so the biopsy is done, the patient is sitting up, getting ready to leave.

What is our post -procedure care instruction to ensure uncomplicated healing?

Instruct the patient to keep the incision clean and dry.

They should take daily showers until any soreness fades.

When drying off, they must blot the area dry.

No rubbing, as friction will disrupt the site.

Right, and a really crucial instruction, do not pick at or remove the healing scab.

Yes.

They should avoid intercourse for two to three days.

You can reassure them that, given the small size of the punch, the site will become practically invisible in just one to two weeks.

Oh, that's fast.

It is.

But they also must know the red flags.

They need to call your clinic if they experience increasing redness, uncontrolled pain, malodorous or bloody drainage, or a fever of 100 .5 degrees Fahrenheit or higher.

Naturally, you'll schedule a return follow -up to discuss the biopsy results and any necessary treatment recommendations.

But our clinical care does not end when the biopsy heals.

Definitely not.

This brings us to a major focus of the chapter, which is teaching vulvar self -examination, or VSE,

because most vulvar malignancies are physically visible long before they cause systemic issues.

Teaching VSE is considered mandatory for women who are sexually active or who are older than 18.

It is about creating a lifelong habit of early detection.

Yeah.

And the steps to teach are incredibly straightforward.

First, ensure the patient understands basic vulvar anatomy and functions so they know what normal looks like for their own body.

Second, teach them the proper use of a handheld mirror to optimize their view.

And they should perform this examination monthly, specifically between menses, and report any new growths, color changes, or persistent itching immediately.

It is a simple intervention, but historically it's one that isn't discussed as routinely as, say, breast self -exams.

Normalizing the VSE is a critical responsibility for your clinical practice.

Think about how truly empowering that vulvar self -exam is.

By taking the time to teach a patient how to use a simple handheld mirror once a month, you aren't just sending them home to heal from a minor 15 -minute procedure.

You are fundamentally shifting them from being a passive recipient of health care into an active, lifelong sentinel for their own well -being.

You are teaching them how to check their own dashboard.

A 15 -minute biopsy appointment is actually an opportunity to alter the trajectory of a patient's long -term health literacy.

I love that.

So the next time that check engine light of long -standing Pertis comes into your clinic, don't ignore it.

Look under the hood.

A massive thank you from the Last Minute Lecture Team for joining us on this deep dive.

Keep studying.

Keep asking questions, and we will catch you on the next one.